Nina Mohammed, MD
Obstetrics & Gynecology · Wayne, NJNPI 1194751016
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,088 of the $1,580 with a category attached, or 68.9%. 18 manufacturers reported payments, led by Celularity Inc. at 28.2% of the total. Reporting peaked in 2019 at $631 and has fallen 56.2% since, to $276 in 2025.
Across 66 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$446
- AbbVie$223
- Bayer$126
- Mayne Pharma Commercial LLC$98
- Lupin Inc.$97
- Hologic Sales And Service, LLC$89
- plus $500 from 12 others
What the payments were for
- Speaking & faculty fees$40025%
- Food & beverage$1,08869%
- Education$926%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 6 | $446 |
| AbbVie(2 entities) | 16 | $223 |
| Bayer | 5 | $126 |
| Mayne Pharma Commercial LLC | 6 | $98 |
| Lupin Inc. | 7 | $97 |
| Hologic Sales And Service, LLC | 1 | $89 |
| Exeltis, USA Inc. | 4 | $75 |
| Astellas Pharma US Inc | 4 | $72 |
| Millicent US Inc | 2 | $64 |
| Therapeuticsmd, Inc. | 4 | $56 |
| AMAG Pharmaceuticals, Inc. | 3 | $47 |
| Alydia Health | 1 | $40 |
| Johnson & Johnson | 1 | $37 |
| Smith+Nephew | 1 | $36 |
| Pfizer | 2 | $30 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $15 |
| Meditrina | 1 | $12 |
How this compares
$1,580 in reported general payments places this provider in the 70th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $3,336 |
| Alendronate Sodium | 25 | $153 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wayne
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.